A new study demonstrates a chemical catalysis path for making an existing class of biomaterials called PHAs — already gaining momentum in industrial settings — even more commercially viable and structurally diverse.
A new study demonstrates a chemical catalysis path for making an existing class of biomaterials called PHAs — already gaining momentum in industrial settings — even more commercially viable and structurally diverse.